Haemodynamic performance and long-term durability are central to TAVI lifetime management.
Windecker et al. review contemporary THV platforms, highlighting challenges in cross-device comparisons, interpretation of valve haemodynamics and limitations of current evidence.
eurointervention.pcronline.c…@PPibarot@VDelgadoGarcia@DaijiroTomii
Here are some tips I learned from @rotamonster over the years
1) Distal wire position provides support, can help in preventing a stuck burr & occasionally centralizing the burr
2) Perforations are not just related to the angle, but loss of a coaxial guide catheter that inadvertently redirects the burr
3) Speed: (Safety & comfort) see video
Presented at #ScientificSessions26:
In patients with atrioventricular block, left bundle-branch pacing resulted in a lower incidence of a composite of death, hospitalization for heart failure, or pacing-induced cardiomyopathy than right ventricular pacing. Full OptimPacing trial results: nej.md/4favsI9@AHAScience
Excited to share peripheral runoff 3d tinyurl.com/aoro3d, a free, browser based simulator. Building this helped me understand projections and lesion hemodynamics.
Schematic teaching model built on simplified physics, not for procedural planning. @SVM_tweets@EVToday
If Not Periprocedural Myocardial Injury, Or Vascular Complications, Then What?
The latest CHIP-BCIS3 analysis adds another twist to the tale. While mAFP use was associated with higher rates of PPMI and CV death, the former only partially explained the latter.
This is perplexing. That mAFP failed to outperform standard-of-care HR-PCI is understandable, but the association with higher mortality is unexpected, and at odds with our clinical experience.
The fig. below, from the supplement, shows that the curves diverge on Day 1. Whatever the mechanism, it must be procedure-related.
My best guess? Myocardial stunning, reflected by loss of pulse pressure (LOPP). Perhaps the real story here is that:
1) Stunning can occur without myocardial necrosis.
2) LOPP may impose an independent, additive burden on patients undergoing HR-PCI.
An intriguing possibility! 🤔
CHIP-BCIS3 trial secondary analysis: Microaxial flow pump use during complex PCI was associated with a higher risk of cardiovascular death, which was only partially mediated by procedure-related myocardial injury.
Download slides here: clinicaltrialresults.org/wp-…
Coronary CT #CCTA takes center stage at #TCT2026!
A mobile CT scanner right in the Expo Hall, where attendees are undergoing coronary CT scans with real-time analysis using @HeartFlow technology.
Bringing the future of CT-guided PCI directly to TCT!
#TCT2026: PARADIGM met its primary endpoint, with favorable short-term outcomes. The results support this transcatheter device as a promising therapeutic option for paravalvular leak closure. 🔗 bit.ly/4BECH4U#JACCINT@crfheart
🚨 PROGRESS results are out! TAVR is superior to clinical surveillance in selected patients with MODERATE aortic stenosis and at-risk features. A potential shift toward earlier intervention—with careful patient selection. #TCT2026#TAVR@crfheart Great presentation from @PhilGenereuxMD 👏👏👏
nejm.org/doi/full/10.1056/NE…